JP2023510982A5 - - Google Patents
Info
- Publication number
- JP2023510982A5 JP2023510982A5 JP2022544146A JP2022544146A JP2023510982A5 JP 2023510982 A5 JP2023510982 A5 JP 2023510982A5 JP 2022544146 A JP2022544146 A JP 2022544146A JP 2022544146 A JP2022544146 A JP 2022544146A JP 2023510982 A5 JP2023510982 A5 JP 2023510982A5
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- seq
- variable region
- chain variable
- lag3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010069008.9 | 2020-01-21 | ||
| CN202010069008 | 2020-01-21 | ||
| PCT/CN2021/072610 WO2021147837A1 (zh) | 2020-01-21 | 2021-01-19 | 抗lag3单克隆抗体及其制备方法和应用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023510982A JP2023510982A (ja) | 2023-03-15 |
| JP2023510982A5 true JP2023510982A5 (https=) | 2024-01-26 |
| JP7692918B2 JP7692918B2 (ja) | 2025-06-16 |
| JP7692918B6 JP7692918B6 (ja) | 2025-07-17 |
Family
ID=76993109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544146A Active JP7692918B6 (ja) | 2020-01-21 | 2021-01-19 | 抗ｌａｇ３モノクローナル抗体、その製造方法および使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230074657A1 (https=) |
| EP (1) | EP4095159A4 (https=) |
| JP (1) | JP7692918B6 (https=) |
| KR (1) | KR20220131279A (https=) |
| CN (1) | CN114945595A (https=) |
| AU (1) | AU2021210029A1 (https=) |
| BR (1) | BR112022013544A2 (https=) |
| CA (1) | CA3165211A1 (https=) |
| WO (1) | WO2021147837A1 (https=) |
| ZA (1) | ZA202208339B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| JP2024536881A (ja) * | 2021-09-29 | 2024-10-08 | 中山康方生物医▲藥▼有限公司 | 抗ｌａｇ３抗体、医薬組成物、及び使用 |
| WO2023138677A1 (en) * | 2022-01-24 | 2023-07-27 | Crown Bioscience Inc. (Taicang) | Novel anti-lag3 antibodies and derivative products |
| CN119925593B (zh) * | 2023-06-05 | 2025-11-25 | 北京东方百泰生物科技股份有限公司 | 一种抗il-11单克隆抗体的药物制剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| JP6595458B2 (ja) | 2013-09-20 | 2019-10-23 | ブリストル−マイヤーズ スクイブ カンパニー | 腫瘍を処置するための抗ｌａｇ−３抗体と抗ｐｄ−１抗体との組合せ |
| JO3663B1 (ar) * | 2014-08-19 | 2020-08-27 | Merck Sharp & Dohme | الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين |
| CN114853891A (zh) * | 2015-07-22 | 2022-08-05 | 索伦托药业有限公司 | 与lag3结合的抗体治疗剂 |
| TWI756187B (zh) * | 2015-10-09 | 2022-03-01 | 美商再生元醫藥公司 | 抗ｌａｇ３抗體及其用途 |
| US20190330336A1 (en) * | 2015-11-19 | 2019-10-31 | Sutro Biopharma, Inc. | Anti-lag3 antibodies, compositions comprising anti-lag3 antibodies and methods of making and using anti-lag3 antibodies |
| CA3037144A1 (en) | 2016-09-16 | 2018-03-22 | Shanghai Henlius Biotech, Inc. | Anti-pd-1 antibodies |
| KR102294136B1 (ko) * | 2017-04-05 | 2021-08-26 | 에프. 호프만-라 로슈 아게 | 항-lag3 항체 |
| US11339218B2 (en) * | 2017-05-10 | 2022-05-24 | Zhejiang Shimai Pharmaceutical Co., Ltd. | Human monoclonal antibodies against LAG3 and uses thereof |
| WO2019164219A1 (en) * | 2018-02-20 | 2019-08-29 | Institute For Basic Science | Anti-angiopoietin-2 antibodies and uses thereof |
| CN115057931B (zh) * | 2018-02-28 | 2025-08-22 | 广州誉衡生物科技有限公司 | 抗人lag-3抗体及其用途 |
| CN110305215B (zh) * | 2018-03-20 | 2023-11-03 | 基石药业 | 新型抗lag-3抗体多肽 |
| CN110343179B (zh) * | 2018-04-02 | 2024-03-08 | 上海博威生物医药有限公司 | 结合淋巴细胞活化基因-3(lag-3)的抗体及其用途 |
| CN110172099B (zh) * | 2018-08-16 | 2020-03-03 | 上海健信生物医药科技有限公司 | 抗lag-3人源化单克隆抗体分子，抗原结合片段及其医药用途 |
-
2021
- 2021-01-19 EP EP21744582.4A patent/EP4095159A4/en active Pending
- 2021-01-19 BR BR112022013544A patent/BR112022013544A2/pt unknown
- 2021-01-19 WO PCT/CN2021/072610 patent/WO2021147837A1/zh not_active Ceased
- 2021-01-19 KR KR1020227028342A patent/KR20220131279A/ko active Pending
- 2021-01-19 CN CN202180008891.3A patent/CN114945595A/zh active Pending
- 2021-01-19 JP JP2022544146A patent/JP7692918B6/ja active Active
- 2021-01-19 US US17/759,180 patent/US20230074657A1/en active Pending
- 2021-01-19 CA CA3165211A patent/CA3165211A1/en active Pending
- 2021-01-19 AU AU2021210029A patent/AU2021210029A1/en active Pending
-
2022
- 2022-07-26 ZA ZA2022/08339A patent/ZA202208339B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510982A5 (https=) | ||
| CN112135626A (zh) | 抗tigit抗体及其用途 | |
| JP2020079252A5 (https=) | ||
| CN112574307A (zh) | 抗人Claudin18.2抗体及其应用 | |
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| RU2012103212A (ru) | Tlr3 связывающие агенты | |
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| FI3322727T3 (fi) | Humanisoituja tai kimeerisiä CD3-vasta-aineita | |
| JP2023527609A5 (https=) | ||
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| RU2020130795A (ru) | Нейтрализующие антитела к env вич-1 и их применение | |
| RU2012112829A (ru) | Анти-gitr-антитела | |
| RU2009129403A (ru) | Антитела, нейтрализующие цитомегаловирус человека, и их применение | |
| JP2021520825A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2012532851A5 (https=) | ||
| JP2025067915A5 (https=) | ||
| JP2020515277A5 (https=) | ||
| JP2019534892A5 (https=) | ||
| JP2024024114A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| IL280487B2 (en) | Anti-mica/b antibodies that block mica/b shedding and methods of use | |
| JP2025508066A5 (https=) | ||
| JP2023520969A5 (https=) | ||
| CN109721656B (zh) | 靶向rankl的治疗性抗体 |